PolyActiva
PrivateLast Round
Series C
May 30, 2025
Total Funding Raised
$36.12M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PolyActiva operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Series C round in May 2025.
PolyActiva is a biopharmaceutical company developing a biodegradable, sustained-release drug delivery platform for ophthalmic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PolyActiva Comparables
Compare PolyActiva with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ripple Therapeutics | 83% | |
| Peregrine Ophthalmic | 83% | |
| Perfuse Therapeutics | 80% |
For institutional investors. Book with your work email.
PolyActiva Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 30, 2025 | ||||
| Grant | May 7, 2024 | ||||
| VC Round | Jul 24, 2019 | ||||
| VC Round | Aug 30, 2018 | ||||
| Series B | Feb 19, 2013 | ||||
Series A | Jan 1, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PolyActiva Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
| Yuuwa Capital | VC Round, Series B |
| National Reconstruction Fund Corporation | Series C |
| Brandon Capital | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 5, representing 16% of headcount.
- Jun 22, 2026
Monthly visitors grew 34% MoM.
For institutional investors. Book with your work email.
PolyActiva Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PolyActiva's valuation, stock price, and market status.
Is PolyActiva a public or private company?
PolyActiva is a private company.
What is the current stock price of PolyActiva?
PolyActiva is a private company, so its shares have no public market price. Caplight tracks PolyActiva's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PolyActiva worth (valuation)?
Valuation information for PolyActiva is not publicly available.
Can I buy PolyActiva stock?
PolyActiva shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PolyActiva's last funding round?
PolyActiva's most recent funding round was Series C on May 30, 2025.
Who are the main investors in PolyActiva?
Key investors in PolyActiva include CUREator, National Reconstruction Fund Corporation.
Will PolyActiva IPO soon?
No public IPO plans have been announced for PolyActiva.
How can I track PolyActiva secondary market activity?
Caplight tracks bids, offers, and trades in PolyActiva's shares on secondary markets.